The U.S. Food and Drug Administration authorized the first over-the-counter home sample collection kit for COVID-19, the agency announced yesterday.
The LabCorp Pixel COVID-19 Test Home Collection Kit, authorized for individuals 18 years and older, allows for self-collection of a nasal swab at home that can then be sent for testing at LabCorp. Users then receive their test results via a phone call from their health care provider or by email or online portal, depending on whether the results are positive, negative, or invalid.
The use of a home sample collection kit allows users to “access information about their COVID-19 infection status that could aid with determining if self-isolation (quarantine) is appropriate and to assist with health care decisions after discussion with a health care professional,” the FDA notes.
Read more of the original article from MedicalXpress
